摩根大通增持信达生物(01801)约49.78万股 每股作价约82.28港元

Core Viewpoint - Morgan Stanley has increased its stake in Innovent Biologics (01801) by acquiring 497,823 shares at a price of HKD 82.2756 per share, totaling approximately HKD 40.9587 million, resulting in a new holding of about 87,249,700 shares, representing 5.02% ownership [1] Group 1 - Morgan Stanley's recent acquisition of shares indicates a bullish sentiment towards Innovent Biologics [1] - The total investment made by Morgan Stanley amounts to approximately HKD 40.9587 million [1] - Following the purchase, Morgan Stanley's total shareholding in Innovent Biologics is now approximately 87.2497 million shares [1]